Cargando…
Epigenetic assays for chemical biology and drug discovery
The implication of epigenetic abnormalities in many diseases and the approval of a number of compounds that modulate specific epigenetic targets in a therapeutically relevant manner in cancer specifically confirms that some of these targets are druggable by small molecules. Furthermore, a number of...
Autor principal: | Gul, Sheraz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5399855/ https://www.ncbi.nlm.nih.gov/pubmed/28439316 http://dx.doi.org/10.1186/s13148-017-0342-6 |
Ejemplares similares
-
Editorial: Protein–Protein Interactions: Drug Discovery for the Future
por: Rapposelli, Simona, et al.
Publicado: (2021) -
Diversity-Oriented Synthetic Strategies Applied to Cancer Chemical Biology and Drug Discovery
por: Collins, Ian, et al.
Publicado: (2014) -
Drug-Like Protein–Protein Interaction Modulators: Challenges and Opportunities for Drug Discovery and Chemical Biology
por: Villoutreix, Bruno O, et al.
Publicado: (2014) -
The timeline of epigenetic drug discovery: from reality to dreams
por: Ganesan, A., et al.
Publicado: (2019) -
Designing Chimeric
Molecules for Drug Discovery by
Leveraging Chemical Biology
por: Borsari, Chiara, et al.
Publicado: (2020)